Company
Lilly Institute for Genetic Medicine
- Biotech
Description
RNA, DNA, and genetic-medicine research hub translating Lilly's biologics platform into next-generation therapies. Boston MA site.
Lilly Institute for Genetic Medicine is located in the Boston ecosystem.
Related
Prime Medicine ($PRME)Develops one-time genetic therapies using prime editing to locate genome targets and replace faulty DNA segments for patients with diseases…
MilliporeSigma (Sigma-Aldrich St. Louis)St. Louis operations of MilliporeSigma (life science arm of Merck KGaA, Darmstadt — acquired Sigma-Aldrich 2015).
Harvard Innovation LabsHarvard's startup accelerator + entrepreneurial hub serving students from all 13 Harvard schools.
Ionis Pharmaceuticals ($IONS)Develops RNA- and DNA-targeted medicines for people with serious diseases, with marketed therapies including TEGSEDI and WAYLIVRA for…
Lilly Gateway Labs (San Diego)Eli Lilly biotech incubator at One Alexandria Square Megacampus in Torrey Pines.
AsimovBuilds an end-to-end genetic design platform combining synthetic biology and computational tools for biologics, cell therapy, and gene…
Atomic AIBuilds RNA foundation models and wet-lab assays to predict RNA structure and function, supporting discovery of RNA-targeted small molecules…
Arbor BiotechnologiesDevelops gene editing treatments and genetic medicines using programmable DNA editors for people with genetic diseases, with a focus on CNS…
Verve TherapeuticsSingle-course gene-editing therapies for cardiovascular disease. Cambridge MA; CRISPR-based PCSK9 + ANGPTL3 programs.
Lumen BioscienceDevelops biologic drugs using spirulina algae to make and deliver therapeutic proteins, addressing scalability and cost barriers in…
Tessera TherapeuticsDevelops Gene Writing technology and non-viral delivery methods to make targeted genome alterations for therapies addressing major unmet…
Life BiosciencesDevelops epigenetic restoration therapies intended to rejuvenate cells and treat age-related diseases, with an initial clinical trial…